NEW YORK, Feb 9 - A group of academic and commercial proteomics researchers announced Friday the official launch of the Human Proteome Organization, which aims to coordinate efforts to better understand the proteome.

“The object of HUPO is to try and get the human proteome project off the ground as soon as possible,” said Adrian Shaw, a spokesman for the organization. “It is also there to raise awareness of proteomics, not just among scientists, but in government and financial circles.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.